Recent statements, initiatives, and studies from three of the largest producers of pharmaceuticals in the world confirm that pharmaceutical patent holders are taking steps to improve access to medicines in developing countries. GSK, Johnson & Johnson, and Novartis all have publicly available information on their efforts to improve access to medicines. These efforts will be summarized in this article for reference.

More: continued here